97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05574387
(ClinicalTrials.gov)
January 20, 20236/10/2022Metformin as Added on Therapy in Patients With Ulcerative ColitisMetformin, The Biguanide Derivative, as Adjuvant Therapy in Patients With Ulcerative Colitis Treated With MesalamineInflammatory Bowel DiseasesDrug: MetforminTanta UniversityPrincipal Investigator Sahar El-Haggar, Prof Clinical pharmacy Department- Tanta University;Principal Investigator Sahar Hegazy, Prof Clinical pharmacy Department- Tanta University;Principal Investigator Mostafa Mahmoud Bahaa El-Dien Pharmacy Practice Department- Horus UniversityRecruiting18 Years75 YearsAll46Phase 2Egypt
2NCT05553704
(ClinicalTrials.gov)
November 1, 202220/9/2022Metformin in Patients With Ulcerative Colitis Treated With MesalamineClinical Study to Compare the Possible Efficacy of Metformin in Patients With Ulcerative Colitis Treated With MesalamineInflammatory Bowel DiseasesDrug: MetforminTanta UniversityNULLRecruiting18 Years75 YearsAll52Phase 2Egypt
3NCT04750135
(ClinicalTrials.gov)
February 7, 20217/2/2021Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative ColitisAssessment of Metformin as Adjuvant Therapy in Patients With Ulcerative ColitisUlcerative Colitis;Inflammatory Bowel DiseasesDrug: metformin 500 mg TID Oral Tablet;Drug: PlaceboNational Hepatology & Tropical Medicine Research InstituteNULLNot yet recruiting18 Years65 YearsAll40Phase 2Egypt